Pharming GAAP EPS of -$0.02 beats by $0.01, revenue of $79.09M beats by $15.15M
Source: SeekingAlpha
2025-05-09 09:35:20 ET
More on Pharming
- Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation
- Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript
- Pharming Group: Small Dutch Company With Strong Revenues
- Pharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growth
- Seeking Alpha’s Quant Rating on Pharming
Read the full article on Seeking Alpha
For further details see:
Pharming GAAP EPS of -$0.02 beats by $0.01, revenue of $79.09M beats by $15.15M
Pharming Group N.V.
NASDAQ: PHAR
PHAR Trading
3.28% G/L:
$16.36 Last:
5,035 Volume:
$16.25 Open:
PHAR Latest News
PHAR Stock Data
$1,106,258,522
65,794,170
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
